U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07941011) titled 'Hyaluronic Acid Barrier in Parotidectomy' on Nov. 10.
Brief Summary: The purpose of this study is to evaluate the efficacy of AxoGuard HA+ (hyaluronic acid nerve protector) in preventing Frey syndrome following parotidectomy. A parotidectomy is a surgical procedure to remove all or part of the parotid gland, the largest salivary gland located near the ear and jaw. The specific aims are to determine whether placement of AxoGuard HA+ during parotidectomy can significantly reduce both clinical and subclinical incidence of Frey syndrome compared to standard surgical technique alone.
Study Start Date: Jan. 01, 2027
Study Type: INTERVEN...